Inventor
JOHANNES-PETER STASCH
Inventor
DE
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes31%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
C07CAcyclic or carbocyclic compounds23%
C07DHeterocyclic compounds15%
PatentTitleYear
12,427,131Stimulators and/or activators of soluble guanylate cyclase (sGC) in combination with an inhibitor of neutral endopeptidase (NEP inhibitor) and/or an angiotensin AII antagonist and the use thereof202512,064,429Substituted 5-fluoro-1H-pyrazolopyridines and their use202411,439,642Substituted 5-fluoro-1H-pyrazolopyridines and their use202211,377,417Branched 3-phenylpropionic acid derivatives and their use2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2024Patents assigned to ADVERIO PHARMA GMBH (2)· patent assignee history
2022Patents assigned to BAYER IP GMBH (1)· patent assignee history
2022–2024Based in DE· patent location history
2025Patents assigned to Bayer Pharma AG (1)· patent assignee history
2025Based in IT· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ADVERIO PHARMA GMBH | 2 | 2022–2024 |
| BAYER IP GMBH | 1 | 2022 |
| Bayer Pharma AG | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| DE | 3 | 2022–2024 |
| IT | 1 | 2025 |